Document Detail


Combined local and systemic methotrexate treatment of viable ectopic pregnancy: outcomes of 31 cases.
MedLine Citation:
PMID:  18626871     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Medical treatment of viable unruptured ectopic pregnancies by systemic methotrexate (MTX) is controversial due to elevated failure rates. This study describes a combined local and systemic MTX administration and compares the outcomes between viable ectopics in different locations. METHODS: This retrospective study evaluated 31 patients treated with combined local (sonographically guided) and systemic MTX for viable, unruptured ectopic pregnancies. Success was defined by pregnancy resolution without surgical intervention. Details on subsequent pregnancies were obtained via telephone questionnaires. RESULTS: The ectopic pregnancies were located in the fallopian tube (n = 23), cesarean section scar (n = 5), and intramural portion of the tube (interstitial pregnancy) (n = 3). beta-Human chorionic gonadotropin levels and gestational weeks were similar. The combined treatment was successful in 73.9%, 100%, and 66.7% of cases, respectively (p > 0.05). Details regarding reproductive outcomes were available for 28 women (90.3%). Eighteen of the 24 women attempting to conceive became pregnant, and 15 of these had at least one live birth. There were three subsequent tubal pregnancies, all in patients with previous tubal pregnancies. CONCLUSION: Combined MTX administration is effective and safe for treating viable cesarean scar pregnancies but is less successful for viable tubal or interstitial pregnancies. Reproductive outcomes following the combined MTX treatment are comparable to other treatment modalities for ectopic pregnancy.
Authors:
Noam Smorgick; Zvi Vaknin; Moti Pansky; Reuvit Halperin; Arie Herman; Ron Maymon
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of clinical ultrasound : JCU     Volume:  36     ISSN:  1097-0096     ISO Abbreviation:  J Clin Ultrasound     Publication Date:    2008 Nov-Dec
Date Detail:
Created Date:  2008-10-20     Completed Date:  2009-02-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401663     Medline TA:  J Clin Ultrasound     Country:  United States    
Other Details:
Languages:  eng     Pagination:  545-50     Citation Subset:  IM    
Copyright Information:
(c) 2008 Wiley Periodicals, Inc.
Affiliation:
Department of Obstetrics and Gynecology, Assaf Harofe Medical Center, Sackler Faculty of Medicine, Zerifin 70300, Tel Aviv University, Tel Aviv, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Drug Administration Routes
Female
Humans
Methotrexate / therapeutic use*
Nucleic Acid Synthesis Inhibitors / therapeutic use*
Pregnancy
Pregnancy, Ectopic / drug therapy*,  ultrasonography
Retrospective Studies
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Nucleic Acid Synthesis Inhibitors; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Paratracheal lymph nodes: a new sonographic finding in autoimmune thyroiditis.
Next Document:  Extracranial and intracranial vertebral artery dissection: long-term clinical and duplex sonographic...